Kavita Patel

Dr. Kavita Patel, a medical contributor at NBC News and MSNBC, dives into the recent turmoil in the pharmaceutical industry, especially as Novo Nordisk's shares hit an 18-month low due to new Medicare price negotiations. She discusses the implications for the weight loss drug market and investor concerns about healthcare under changing political conditions. On another note, she speculates about Intel's stock surge driven by M&A rumors and what potential deals could mean for the tech sector.

Dr. Kavita Patel, a former policy director in the Obama administration, shares her insights on the intersection of healthcare and market dynamics. Steve Leisman covers Fed Chair Jerome Powell's latest interest rate update, emphasizing a cautious economic outlook. The discussion also highlights Amazon's surprising move into telehealth, which is impacting Hims & Hers significantly. Both guests delve into the implications of political shifts on public health and how market reactions are shaped by monetary policy uncertainties.

Join Pulitzer Prize-winning journalist Laurie Garrett and health policy expert Dr. Kavita Patel as they dissect America's escalating health and science crisis. They delve into the alarming drop in scientific funding and its repercussions, stressing the urgent need for integrity in research. The conversation reveals a looming two-tiered healthcare system, where access to medications becomes increasingly unequal. With an emphasis on critical inquiry, they encourage listeners to engage thoughtfully with health information and advocate for essential services amidst budget cuts.